1 completed, 1 not yet recruiting, 1 unknown. 3 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 1, Not yet recruiting 1, Unknown 1 |
| Phase 2 | 1 | Unknown 1 |
Follow LiteVax BV: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Immunogenicity of PCV-LITE, a Low-dose of Pneumococcal Conjugate Vaccine With LiteVax Adjuvant PCV-LITE, PCV-LITE+LVA, PCV20 - Vaccine Reaction | Phase 1 | Not yet recruiting | LiteVax BV | 80 | 2025-07-01 | 2025-05-22 |
| Safety, Tolerability, Immunogenicity and Immunological Mechanisms of TETRALITE, a Novel Seasonal Influenza Vaccine TETRALITE - Vaccination Reaction | Phase 1 / Phase 2 | Unknown | LiteVax BV | 84 | 2024-01-29 | 2024-07-29 |
| Safety, Tolerability, and Immunogenicity of TETRALITE, a Novel Adjuvanted, Low-dose Influenza Vaccin TETRALITE - Influenza | Phase 1 | Completed | LiteVax BV | 60 | 2022-10-03 | 2024-01-25 |
Influenza, Human (2)
Belgium (2)
2023 (1)